Related Experiment Video
Updated: Aug 19, 2026
An Optimized Protocol for Candida albicans Infection in Schmidtea mediterranea to Study Fungal Pathogenesis and Host Defense
Published on: April 17, 2026
Evaluation of host immune responses to pulmonary cryptococcosis using a temperature-sensitive C. neoformans
Floyd L Wormley1, Gary M Cox, John R Perfect
1Department of Medicine/Division of Infectious Diseases, Duke University Medical Center, Duke South, Stead Bldg, Box 3353, Durham, NC 27710, USA. floyd.wormley@duke.edu
Abstract:
Cryptococcus neoformans is an opportunistic fungal pathogen that threatens individuals with impaired cell-mediated immunity (CMI). Presently, there are no standardized vaccines available to prevent cryptococcal infections and conventional anti-fungal drug therapy does not induce host immune reactivity and thus cannot efficiently resolve C. neoformans infections in immunocompromised individuals. The present study was designed to characterize pulmonary immune responses following infection with an avirulent temperature-sensitive (ts) mutant, calcineurin A1 (cna1) compared to the pathogenic C. neoformans strain H99 and its potential to induce protective anti-cryptococcal immunity. Host CMI responses in cna1-inoculated mice were observed to be dose-dependent, and comprise increases in pulmonary macrophages and CD4(+) T lymphocytes. However, cytokine analysis demonstrated a mixed pulmonary cytokine response (increases in IL-4, and MCP-1) with no induction of IFN-gamma. Also, pre-immunization with the ts cna1 mutant did not result in protection from a subsequent secondary pulmonary infection with the pathogenic C. neoformans strain H99. Taken together, these results suggest that host pulmonary CMI responses to the ts cna1 mutant that is eventually eliminated from the host without the induction of IFN-gamma appear to be dose-dependent, diverse, and require further stimulation to induce C. neoformans-specific Th1-type cytokine responses to resolve subsequent experimental pulmonary cryptococcal infections.
Insights
This study investigated immune responses to a weakened Cryptococcus neoformans strain in mice. The strain induced dose-dependent immune cell increases but lacked protective immunity against infection.
Area of Science:
- Immunology
- Mycology
- Infectious Diseases
Background:
- Cryptococcus neoformans is an opportunistic fungal pathogen impacting immunocompromised individuals.
- Current treatments lack immune-boosting capabilities for effective cryptococcal infection resolution.
- No standardized vaccines exist to prevent cryptococcal infections.
Purpose of the Study:
- To characterize pulmonary immune responses to an avirulent, temperature-sensitive (ts) C. neoformans mutant (cna1).
- To compare immune responses to the ts cna1 mutant versus the pathogenic strain H99.
- To evaluate the ts cna1 mutant's potential to induce protective anti-cryptococcal immunity.
Main Methods:
- Mice were inoculated with the ts cna1 mutant and compared to those infected with pathogenic C. neoformans H99.
- Pulmonary immune cell populations (macrophages, CD4+ T lymphocytes) were analyzed.
- Pulmonary cytokine profiles, including IL-4, MCP-1, and IFN-gamma, were measured.
Main Results:
- Immune responses to the ts cna1 mutant were dose-dependent, increasing pulmonary macrophages and CD4+ T lymphocytes.
- A mixed cytokine response was observed, with elevated IL-4 and MCP-1, but no IFN-gamma induction.
- Pre-immunization with the ts cna1 mutant did not confer protection against subsequent infection with pathogenic C. neoformans H99.
Conclusions:
- Pulmonary cell-mediated immunity (CMI) responses to the ts cna1 mutant are dose-dependent and diverse.
- The ts cna1 mutant is eliminated without inducing protective IFN-gamma responses.
- Further stimulation is needed to elicit C. neoformans-specific Th1-type cytokine responses for resolving infections.
